Ann-kathrin Reuschl
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Signatures of omicron-like adaptation in early SARS-CoV-2 variants and chronic infection.
Journal: Cell reports
Published: February 27, 2025
HIV-1 signalling remodels nuclear pores to licence infection.
Journal: Nature
Published: September 02, 2024
Macrocycle-based PROTACs selectively degrade cyclophilin A and inhibit HIV-1 and HCV.
Journal: Nature communications
Published: February 28, 2023
SARS-CoV-2 evolution influences GBP and IFITM sensitivity.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 24, 2023
SARS-CoV-2 variants evolve convergent strategies to remodel the host response.
Journal: Cell
Published: December 20, 2022
Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariants.
Journal: Nature microbiology
Published: July 22, 2022
Publisher Correction: Evolution of enhanced innate immune evasion by SARS-CoV-2.
Journal: Nature
Published: March 25, 2022
Evolutionary remodelling of N-terminal domain loops fine-tunes SARS-CoV-2 spike.
Journal: EMBO reports
Published: November 12, 2021
Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19.
Journal: Life science alliance
Published: August 18, 2021
Executable network of SARS-CoV-2-host interaction predicts drug combination treatments.
Journal: NPJ digital medicine
Published: July 29, 2021
Last Updated: 09/26/2026